BNT162b2 mRNA COVID-19 vaccine effectiveness in pregnancy: Emulating trial NCT04754594 using observational data from Norwegian health registries
Open Access
Abstract
No abstract availableKeywords
Funding Information
- European Commission
- European Health and Digital Executive Agency
This publication has 31 references indexed in Scilit:
- Uptake of COVID-19 vaccines and association with hospitalisation due to COVID-19 in pregnancy: Retrospective cohort studyVaccine, 2024
- Individual and familial factors associated with mRNA COVID-19 vaccine uptake in pregnancy: A large-scale registry-based linkage studyVaccine, 2024
- Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational studyeClinicalMedicine, 2023
- Emulation of Randomized Clinical Trials With Nonrandomized Database AnalysesJAMA, 2023
- Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022International Journal of Infectious Diseases, 2023
- Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in IsraelNature Communications, 2022
- Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant WomenJAMA, 2021
- Safe Expectations: Current State and Future Directions for Medication Safety in Pregnancy ResearchClinical Therapeutics, 2019
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 yearsActa Obstetricia et Gynecologica Scandinavica, 2000